Teresa Caballero-Velázquez (T Caballero-Velazquez, T Caballero-Velázquez)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 13

Top Venues

Cancers

Bone marrow transplantation

Journal of personalized medicine

Clinical cancer research : an official journal of the American Association for Cancer Research

Hospital Virgen del Rocío

Universidad de Salamanca (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Hospital Virgen del Rocío

Spain

MD :: Haematology

Education History

Universidad de Salamanca - Dec 13 2010

Spain

PHD :: Departament of medicine

Publications

C Marrero-Cepeda, Teresa Caballero-Velázquez, S Garcia-Canale, F Martin-Dominguez, N Rodriguez-Torres, I Espigado-Tocino, C Blazquez-Goñi, H Andrade-Ruiz, José Antonio Pérez-Simón
Monocytosis as prognostic factor for chronic graft versus host disease. Bone marrow transplantation 59 (9) (2024)
C Marrero-Cepeda, Teresa Caballero-Velázquez, S Garcia-Canale, F Martin-Dominguez, N Rodriguez-Torres, I Espigado-Tocino, C Blazquez-Goñi, H Andrade-Ruiz, José Antonio Pérez-Simón
Monocytosis as prognostic factor for chronic graft versus host disease. Bone marrow transplantation (2024)
Rosario M Morales-Camacho, Teresa Caballero-Velázquez, Juan José Borrero, Ricardo Bernal, Concepción Prats-Martín
Hematological Neoplasms with Eosinophilia. Cancers 16 (2) (2024)
Rosario M Morales-Camacho, Teresa Caballero-Velázquez, Juan José Borrero, Ricardo Bernal, Concepción Prats-Martín
Hematological Neoplasms with Eosinophilia. Cancers 16 (2) (2024)
Teresa Caballero-Velázquez, Olga Pérez-López, Ana Yeguas Bermejo, Eduardo Rodríguez Arbolí, Enrique Colado, Amparo Sempere Talens, María Belén Vidriales, María Solé-Rodríguez, Covadonga Quirós Caso, Estefanía Pérez López, Marta Reinoso Segura, Concepción Prats-Martín, Pau Montesinos, José Antonio Pérez-Simón
Prognostic Value of Measurable Residual Disease in Patients with AML Undergoing HSCT: A Multicenter Study. Cancers 15 (5) (2023)
Fernando Ramos, María Lourdes Hermosín, Marta Fuertes-Núñez, Pilar Martínez, Carlos Rodriguez-Medina, Manuel Barrios, Francisco Ibáñez, Teresa Bernal Del Castillo, Maria Teresa Olave, Miguel Ángel Álvarez, María Vahí, Teresa Caballero-Velázquez, Bernardo González, Albert Altés, Lorena García, Pascual Fernández, María Antonia Durán, Rocío López, Montserrat Rafel, Josefina Serrano
Survival Outcomes and Health-Related Quality of Life in Older Adults Diagnosed with Acute Myeloid Leukemia Receiving Frontline Therapy in Daily Practice. Journal of personalized medicine 13 (12) (2023)
Fernando Ramos, María Lourdes Hermosín, Marta Fuertes-Núñez, Pilar Martínez, Carlos Rodriguez-Medina, Manuel Barrios, Francisco Ibáñez, Teresa Bernal Del Castillo, Maria Teresa Olave, Miguel Ángel Álvarez, María Vahí, Teresa Caballero-Velázquez, Bernardo González, Albert Altés, Lorena García, Pascual Fernández, María Antonia Durán, Rocío López, Montserrat Rafel, Josefina Serrano
Survival Outcomes and Health-Related Quality of Life in Older Adults Diagnosed with Acute Myeloid Leukemia Receiving Frontline Therapy in Daily Practice. Journal of personalized medicine 13 (12) (2023)
Teresa Caballero-Velázquez, Olga Pérez-López, Ana Yeguas Bermejo, Eduardo Rodríguez Arbolí, Enrique Colado, Amparo Sempere Talens, María Belén Vidriales, María Solé-Rodríguez, Covadonga Quirós Caso, Estefanía Pérez López, Marta Reinoso Segura, Concepción Prats-Martín, Pau Montesinos, José Antonio Pérez-Simón
Prognostic Value of Measurable Residual Disease in Patients with AML Undergoing HSCT: A Multicenter Study. Cancers 15 (5) (2023)
Eduardo Rodríguez Arbolí, Catherine J Lee, Teresa Caballero-Velázquez, Maria Carmen Martinez Munoz, Clara García-Calderón, María Reyes Jiménez-León, María Aránzazu Bermúdez-Rodríguez, Lucía López Corral, Ana Triguero, Lynn Onstad, Mitchell E Horwitz, Stefanie Sarantopoulos, Stephanie J Lee, José Antonio Pérez-Simón
Targeting Hedgehog Signaling with Glasdegib in Patients with Refractory Sclerotic Chronic GVHD: A Report of Two Phase I/II Trials. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Teresa Lopes Ramos, Estefanía García-Guerrero, Teresa Caballero-Velázquez, Alfonso Rodríguez-Gil, Rocío Caracuel-García, Melanie Nufer, María José Robles-Frías, María Victoria Barbado, José Antonio Pérez-Simón
Delayed administration of ixazomib modifies the immune response and prevents chronic graft-versus-host disease. Bone marrow transplantation 56 (12) (2021)
Salvador Chulián, Álvaro Martínez, Victor M Pérez-García, María Rosa, Cristina Blázquez Goñi, Juan Francisco Rodríguez Gutiérrez, Lourdes Hermosín-Ramos, Águeda Molinos Quintana, Teresa Caballero-Velázquez, Manuel Ramírez, Ana Castillo Robleda, Juan Luis Fernández-Martínez
High-Dimensional Analysis of Single-Cell Flow Cytometry Data Predicts Relapse in Childhood Acute Lymphoblastic Leukaemia. Cancers 13 (1) (2020)
Virginia Escamilla Gómez, Valentín García-Gutiérrez, Lucía López Corral, García-Cadenas Irene, Ariadna Pérez Martínez, Francisco J Márquez Malaver, Teresa Caballero-Velázquez, Pedro A González Sierra, María C Viguria Alegría, Ingrid M Parra Salinas, Cristina Calderón Cabrera, Marta González Vicent, Nancy Rodríguez Torres, Rocío Parody Porras, Christelle Ferra Coll, Guillermo Orti, David Valcárcel Ferreiras, Rafael De la Cámara LLanzá, Paula Molés, Kyra Velázquez-Kennedy, María João Mende, Dolores Caballero Barrigón, Estefanía Pérez, Rodrigo Martino Bofarull, Silvanna Saavedra Gerosa, Jorge Sierra, Marc Poch, María T Zudaire Ripa, Miguel A Díaz Pérez, Blanca Molina Angulo, Isabel Sánchez Ortega, Jaime Sanz Caballer, Juan Montoro Gómez, Ildefonso Espigado Tocino, José A Pérez-Simón, null null
Ruxolitinib in refractory acute and chronic graft-versus-host disease: a multicenter survey study. Bone marrow transplantation 55 (3) (2019)
Teresa Caballero-Velázquez, C Calderón-Cabrera, L López-Corral, N Puig, Francisco J Márquez Malaver, E Pérez-López, C García-Calderón, C M Rosso-Fernández, D Caballero Barrigón, J Martín, M V Mateos, J San Miguel, J A Pérez-Simón, null null
Efficacy of bortezomib to intensify the conditioning regimen and the graft-versus-host disease prophylaxis for high-risk myeloma patients undergoing transplantation. Bone marrow transplantation 55 (2) (2019)

Teresa Caballero-Velázquez.css-eqlu8i{font-size:small;padding-left:4px;} (T Caballero-Velazquez, T Caballero-Velázquez)

Publication Activity (10 Years)

Top Topics

Top Venues

Teresa Caballero-Velázquez (T Caballero-Velazquez, T Caballero-Velázquez)